Delta/mu opioid receptor interactions in operant conditioning assays of pain-depressed responding and drug-induced rate suppression: assessment of therapeutic index in male Sprague Dawley rats
- 88 Downloads
Rationale and objectives
Although delta/mu receptor interactions vary as a function of behavioral endpoint, there have been no assessments of these interactions using assays of pain-depressed responding. This is the first report of delta/mu interactions using an assay of pain-depressed behavior.
A mult-cycle FR10 operant schedule was utilized in the presence of (nociception) and in the absence of (rate suppression) a lactic acid inflammatory pain-like manipulation. SNC80 and methadone were used as selective/high efficacy delta and mu agonists, respectively. Both SNC80 and methadone alone produced a dose-dependent restoration of pain-depressed responding and dose-dependent response rate suppression. Three fixed ratio mixtures, based on the relative potencies of the drugs in the nociception assay, also produced dose-dependent antinociception and sedation. Isobolographic analysis indicated that all three mixtures produced supra-additive antinociceptive effects and simply additive sedation effects.
The therapeutic index (TI) inversely varied as a function of amount of SNC80 in the mixture, such that lower amounts of SNC80 produced a higher TI, and larger amounts produced a lower TI. Compared to literature using standard pain-elicited assays, the orderly relationship between SNC80 and TI reported here may be a unique function of assessing pain-depressed behavior.
KeywordsOpioid receptor interactions Pain-depressed behaviors Operant conditioning SNC80 Rats
Compliance with ethical standards
All studies were conducted in accordance with the Guide for the Care and Use of Laboratory Animals as adopted by the National Institutes of Health, and procedures were approved by the University of New England Institutional Animal Care and Use Committee (IACUC).
- Erbs E, Faget L, Scherrer G, Matifas A, Filliol D, Vonesch JL, Koch M, Kessler P, Hentsch D, Birling M, Koutsourakis M, Vasseur L, Veinante P, Kieffer BL, Massotte D (2015) A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks. Brain Struct Funct 220:677–702CrossRefPubMedGoogle Scholar
- IOM (Institute of Medicine) (2011) Relieving pain in America: a blueprint for transforming prevention, care, education, and research. The National Academies Press, Washington, DCGoogle Scholar
- Jutkiewicz EM, Kaminsky ST, Rice KC, Traynor JR, Woods JH (2005) Differential behavioral tolerance to the δ-opioid agonist SNC80 [(+)-4-[(αR)-α-[(2S,5R)-2,5-Dimethyl-4-(2-propenyl)-1-peperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats. J Pharmacol Exp Ther 315:414–422CrossRefPubMedPubMedCentralGoogle Scholar
- Kandel ER, Schwartz JH, Jessell TM, Siegelbaum SA, Hudspeth AJ (2013) Principles of neural science, 5th edn. McGraw Hill, NYGoogle Scholar
- Leitl MD, Potter DN, Cheng K, Rice KC, Carlezon WA, Negus SS (2014) Sustained pain-related depression of behavior: effects of intraplantar formalin and complete freund’s adjuvant on intracranial self-stimulation (ICSS) and endogenous kappa opioid biomarkers. Molec. Pain 10:62Google Scholar
- Matsumoto K, Narita M, Muramatsu N, Nakayama T, Misawa K, Kitajima M, Tashima K, Devi L, Suzuki T, Takayama H, Horie S (2014) Orally active opioid μ/∂ dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice. J Pharmacol Exp Ther 348:383–392CrossRefPubMedGoogle Scholar
- Mosberg HI, Yeomans L, Anand JP, Porter V, Sobczyk-Kojiro K, Traynor JR, Jutkiewicz EM (2014) Development of a bioavabilable μ opioid receptor (MOPr) agonist, ∂ opioid receptor (DOPr) antagonist peptide that evokes antinociception without development of acute tolerance. J Med Chem 57:3148–3153CrossRefPubMedPubMedCentralGoogle Scholar
- Narita M, Suzuki T (2003) Delta opioid receptor-mediated antinociception/analgesia. In: Chang KJ, Porreca F, Woods JH (eds) The delta receptor, 1st edn. CRC Press, Boca Raton, FL, pp 331–354Google Scholar
- Porreca F, LoPresti D, Ward SJ (1990a) Opioid agonist affinity in the guinea-pig ileum and mouse vas deferens. Eur J Pharamcol 179:129–139Google Scholar
- Shalmi CL (2004) Opioids for non-malignant pain—issues and controversy. In: Warfield CA, Bajwa ZH (eds) Principles and practice of pain medicine. McGraw-Hill, pp 601–611Google Scholar
- Stevenson GW, Folk JE, Rice KC, Negus SS (2005) Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 and heroin. J Pharmacol Exp Ther 314:221–231CrossRefPubMedGoogle Scholar
- Stevenson GW, Bilsky E, Negus SS (2006) Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice. J Pain 7(6):408–416Google Scholar
- Stevenson GW, Cormier J, Mercer H, Adams C, Dubar C, Negus SS, Bilsky EJ (2009) Targeting paindepressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice. Life Sci 85:309–315Google Scholar
- Stevenson GW, Mercer H, Cormier J, Dunbar C, Benoit L, Adams C, Jezierski J, Luginbuhl A, Bilsky EJ (2011) Monosodium iodoacetate-induced osteoarthritis pain-depressed wheel running in rats: implications for preclinical behavioral assessment of chronic pain. Pharmacol Biochem Behav 98:35–42Google Scholar
- Stevenson GW, Luginbuhl A, Dunbar C, LaVigne J, Dutra J, Atherton P, Bell B, Cone K, Giuvelis D, Polt R, Streicher JM, Bilsky EJ (2015) The mixed-action delta/mu opioid agonist MMP-2200 does not produce conditioned place preference but does maintain drug self-administration in rats, and induces in vitro markers of tolerance and dependence. Pharmacol Biochem Behav 132:49–55CrossRefPubMedPubMedCentralGoogle Scholar
- Su Y-F, McNutt RW, Chang K-J (1998) Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception. J Pharmcol Exp Ther 287:815–823Google Scholar
- Turk DC&Okifuji A (2004) Psychological aspects of pain. In: Warfield CA, Bajwa ZH (eds) Principles and practice of pain medicine. 3rd ed. McGraw-Hill, pp 139–147Google Scholar
- Warner E, Krivitsky R, Cone K, Atherton P, Pitre T, Lanpher J, Giuvelis D, Bergquist I, King T, Bilsky EJ, Stevenson GW (2015). Evaluation of a postoperative pain-like state on motivated behavior in rats: effects of plantar incision on progressive-ratio food-maintained responding. Drug Dev Res 76(8):432–441Google Scholar